Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2021-03-09
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination Among Israeli Health Care Workers
NCT05308680
Myocarditis Post Vaccination or Multi System Inflammatory Syndrome
NCT05288426
Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
NCT04654988
Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients
NCT00562653
Influence of Corticosteroids on Heart Function
NCT03247153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Covid19 Vaccinated Patients
Patients who are planning to receive Pfizer-BioNTech BNT162b2 vaccines against Covid19
Laboratory Blood Tests
Blood tests to determine liver and kidney functioning, total blood count, and troponin levels
ECG
ECG to determine heart rate and functioning
PCR
PCR test to determine whether patient has Covid19
Antibody test
Antibody test to determine level of antibodies to Covid19
Echocardiography
If Troponin level elevated echocardiography to determine heart function
MRI
If Troponin level elevated MRI to determine heart function
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laboratory Blood Tests
Blood tests to determine liver and kidney functioning, total blood count, and troponin levels
ECG
ECG to determine heart rate and functioning
PCR
PCR test to determine whether patient has Covid19
Antibody test
Antibody test to determine level of antibodies to Covid19
Echocardiography
If Troponin level elevated echocardiography to determine heart function
MRI
If Troponin level elevated MRI to determine heart function
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saif Abu-Moch, MD
Role: PRINCIPAL_INVESTIGATOR
Hillel Yaffe Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillel Yaffe Medical Center
Hadera, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYMC-0046-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.